Congress Trades in Sarepta Therapeutics, Inc. - Common Stock (SRPT)
3 members of Congress have disclosed trading SRPT.
Total trades
13
Purchases
10
Sales
3
Members
3
Est. volume
$128,500
Last traded
Apr 14, 2025
3 members of Congress have disclosed trading Sarepta Therapeutics, Inc. - Common Stock (SRPT), with 13 transactions in total — 10 purchases and 3 sales worth an estimated $128,500 at range midpoints, leaning heavily toward buying. The most active SRPT trader is Gilbert Cisneros (7 disclosures). The most recent disclosed SRPT trade was on Apr 14, 2025.
Every disclosed SRPT trade
| Disclosed | Politician | Type | Amount | Traded | |
|---|---|---|---|---|---|
| May 5, 2025 | Gilbert Cisneros D | Sale | $1,001 - $15,000 | Apr 14, 2025 | filing ↗ |
| Aug 8, 2023 | Josh Gottheimer D | Purchase | $1,001 - $15,000 | Jul 14, 2023 | filing ↗ |
| Jul 6, 2023 | Josh Gottheimer D | Sale | $1,001 - $15,000 | Jun 13, 2023 | filing ↗ |
| Apr 6, 2023 | Josh Gottheimer D | Purchase | $1,001 - $15,000 | Mar 6, 2023 | filing ↗ |
| Apr 3, 2023 | Daniel Goldman | Purchase | $15,001 - $50,000 | Mar 6, 2023 | filing ↗ |
| Dec 8, 2020 | Josh Gottheimer D | Sale | $1,001 - $15,000 | Nov 6, 2020 | filing ↗ |
| Oct 13, 2020 | Gilbert Cisneros D | Purchase | $1,001 - $15,000 | Sep 14, 2020 | filing ↗ |
| Jan 6, 2020 | Josh Gottheimer D | Purchase | $1,001 - $15,000 | Dec 13, 2019 | filing ↗ |
| Nov 7, 2019 | Gilbert Cisneros D | Purchase | $1,001 - $15,000 | Oct 11, 2019 | filing ↗ |
| Nov 7, 2019 | Gilbert Cisneros D | Purchase | $1,001 - $15,000 | Oct 10, 2019 | filing ↗ |
| May 8, 2019 | Gilbert Cisneros D | Purchase | $1,001 - $15,000 | Apr 9, 2019 | filing ↗ |
| Apr 9, 2019 | Gilbert Cisneros D | Purchase | $1,001 - $15,000 | Mar 11, 2019 | filing ↗ |
| Mar 7, 2019 | Gilbert Cisneros D | Purchase | $1,001 - $15,000 | Feb 26, 2019 | filing ↗ |
Most active SRPT traders in Congress
Source: US House Clerk Periodic Transaction Reports. Amounts are disclosed as ranges; estimates use range midpoints. Data may be delayed or contain filer errors. Not investment advice.